Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Exchange Rate Effect (2016 - 2025)

Cytosorbents (CTSO) has disclosed Exchange Rate Effect for 13 consecutive years, with -$146000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 271.76% year-over-year to -$146000.0, compared with a TTM value of $33324.0 through Sep 2025, up 142.96%, and an annual FY2024 reading of -$84676.0, up 15.13% over the prior year.
  • Exchange Rate Effect was -$146000.0 for Q3 2025 at Cytosorbents, down from $259088.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $259088.0 in Q2 2025 and bottomed at -$160491.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$17533.8, with a median of -$4938.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 3150.12% in 2022, then skyrocketed 471.28% in 2025.
  • Year by year, Exchange Rate Effect stood at $27592.0 in 2021, then surged by 402.81% to $138734.0 in 2022, then plummeted by 171.05% to -$98564.0 in 2023, then dropped by 7.22% to -$105676.0 in 2024, then crashed by 38.16% to -$146000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for CTSO at -$146000.0 in Q3 2025, $259088.0 in Q2 2025, and $25912.0 in Q1 2025.